AVEO - AVEO Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5456.21M
Enterprise Value 3333.25M
Trailing P/E N/A
Forward P/E 1-8.25
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)59.84
Price/Book (mrq)N/A
Enterprise Value/Revenue 343.71
Enterprise Value/EBITDA 6-11.85

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Sep 30, 2017

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-369.32%

Management Effectiveness

Return on Assets (ttm)-45.81%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)7.62M
Revenue Per Share (ttm)0.08
Quarterly Revenue Growth (yoy)365.10%
Gross Profit (ttm)2.52M
EBITDA -28.11M
Net Income Avi to Common (ttm)-74.13M
Diluted EPS (ttm)-0.78
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)37.41M
Total Cash Per Share (mrq)0.32
Total Debt (mrq)19.24M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.33
Book Value Per Share (mrq)-0.38

Cash Flow Statement

Operating Cash Flow (ttm)-22.87M
Levered Free Cash Flow (ttm)-12.1M

Trading Information

Stock Price History

Beta 1.19
52-Week Change 3350.77%
S&P500 52-Week Change 323.25%
52 Week High 34.24
52 Week Low 30.50
50-Day Moving Average 32.88
200-Day Moving Average 33.09

Share Statistics

Avg Vol (3 month) 31.7M
Avg Vol (10 day) 32.45M
Shares Outstanding 5118.32M
Float 89.87M
% Held by Insiders 10.63%
% Held by Institutions 152.37%
Shares Short 38.05M
Short Ratio 33.28
Short % of Float 39.90%
Shares Short (prior month) 38.97M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A